ViroPharma Seeks Temporary FDA Block for Generic Vancocin

ViroPharma Inc. sued two federal agencies seeking a court order temporarily blocking approval of generic forms of its biggest product, the antibiotic Vancocin.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.